In addition, down-regulation of ADAM28 with siRNA technology resulted in a lack of weight gain, promotion of insulin sensitivity/glucose tolerance, decreased liver TNF-α levels and reduced blood urea nitrogen, alkaline phosphatase and aspartate aminotransferase in our diet-induced obesity mouse model. Here, ADAM28 is linked to Obesity.